IDIBAPS and Fundació Clínic take part in two of the ERIC (European Research Infrastructure Consortium) consortiums promoted by the European Commissio1
Researchers from the IIBB-CSIC and IDIBAPS have published an article in Oncotarget journal in which they have shown for the first time that diets en1
Dr. Jordi Bruix, Head of the hepatic Oncology Unit at Hospital Clínic de Barcelona, the Hepatic Oncology IDIBAPS research team, the Barcelona Clinic1
Researchers at Hospital Clínic and IDIBAPS lead a study in which a genomic test performed at the time of diagnosis in breast cancer is useful to iden1
Aelix Therapeutics, a drug development company created from the HIVACAT project and specialized in the discovery and development of immunotherapies a1
The CIBERER (Networked Biomedical Research Center for Rare Diseases) has incorporated two new research groups, among them the Pathogenesis of autoim1
IDIBAPS researchers in collaboration with CIBERNED scientists identify for the first time, in a study published in EMBO Molecular Medicine, numerous1
IIBB-CSIC and IDIBAPS researchers have published an article in Scientific Reports describing the role of lysosomes in the damage caused by acetamino1
Hospital Clinic of Barcelona performed pioneer worldwide kidney transplantation by implanting the kidney transvaginally in the recipient. This is a m1
Scientists headed by Raúl Méndez, ICREA research professor at the Institute for Research in Biomedicine (IRB Barcelona), and Mercedes Fernández, at1
